ArticleClinical orthopaedics and related research2018
CORR Insights®: Micrometastatic Drug Screening Platform Shows Heterogeneous Response to MAP Chemotherapy in Osteosarcoma Cell Lines.
Bruno FuchsPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.